Biotech · Public company · Austin, TX, US

Shattuck Labs, Inc.

Ticker STTK · SEC CIK 0001680367

Track this companyFree. Adds Shattuck Labs, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials72 recruiting or active

Pipeline programs10From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline10

SL-325Phase 2 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Azacitidine (AZA)Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
Drug: SL-172154Phase 1 · Cutaneous Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Mirvetuximab + SL-172154Phase 1 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Pegylated Liposomal Doxorubicin + SL-172154Phase 1 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
SL-172154Phase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
SL-172154Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
SL-279252Phase 1 · Squamous Cell Carcinoma of the Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
SL-325Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
VenetoclaxPhase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026

A Study of SL-325 in Crohn's Disease PatientsPHASE2 · RECRUITING · started Oct 21, 2026ClinicalTrials.gov NCT07753850 · fetched Nov 12, 2026
Phase 1 Study of SL-325 in Healthy VolunteersPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 18, 2025ClinicalTrials.gov NCT07158437 · fetched Nov 12, 2026
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian CancersPHASE1 · COMPLETED · started Aug 18, 2022ClinicalTrials.gov NCT05483933 · fetched Nov 12, 2026
Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AMLPHASE1 · TERMINATED · started Mar 17, 2022ClinicalTrials.gov NCT05275439 · fetched Nov 12, 2026
Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or SkinPHASE1 · TERMINATED · started Sep 17, 2020ClinicalTrials.gov NCT04502888 · fetched Nov 12, 2026
Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian CancerPHASE1 · COMPLETED · started Jun 29, 2020ClinicalTrials.gov NCT04406623 · fetched Nov 12, 2026
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasPHASE1 · COMPLETED · started Mar 26, 2019ClinicalTrials.gov NCT03894618 · fetched Nov 12, 2026